(zolmitriptan) nasal spray a serotonin (5-HT)1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years and older.1
ZOMIG Nasal Spray’s efficacy was evaluated in multicenter, double-blind, placebo-controlled studies in both adult and adolescent migraine patients (12-17 yrs). In adult migraineurs, 69% of patients achieved a headache response at 2 hours using the 5-mg dose of ZOMIG Nasal Spray vs. 30.8% of patients on placebo (P<0.01).2
When studied in adolescent migraineurs, 29.7% of adolescent patients had no headache pain at 2 hours using the 5-mg dose of ZOMIG Nasal Spray vs 16.6% of patients on placebo (P<0.001).2
Nearly 70% of adults migraine attacks†
and nearly 80% of adolescent migraine patients‡
who used ZOMIG Nasal Spray 5 mg did not need to use a second dose or another medicine within 24 hours.2
When a migraine strikes, help your patients fast forward to migraine relief with ZOMIG Nasal Spray.
Please see Full Prescribing Information at ZomigHCP.com
† Secondary endpoint (P≤0.0001 vs placebo [27.8%]).3
‡Secondary endpoint (P=0.004 vs placebo [68.4%]).2
- ZOMIG Nasal Spray [package insert].
- Date on File, Impax Laboratories, LLC.
- Charlesworth BR, Dowson AJ, Purdy A, Becky